Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

Shares of Edwards Lifesciences Corp. advanced 3.12% to $81.39 Wednesday, on what proved to be an all-around mixed trading ...

Intuitive Surgical is currently the leader in robotic surgery, thanks to a lineup of products that includes the Ion system, ...

A clutch of post-earnings price target increases by analysts helped raise Medtronic 's (NYSE: MDT) stock at a healthy rate on ...

Raymond James analyst Jayson Bedford reiterated a Hold rating on Medtronic on August 18. The company’s shares closed yesterday at $89.90. Elevate Your Investing Strategy: Take a ...

Even great businesses go through hard times, which is why you'll want to look at this medical device maker and this healthcare-focused REIT today.

Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic ...

The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.

The S&P 500 declined 0.2% on Wednesday, Aug. 20, 2025, as tech stocks slid and minutes from the latest Federal Reserve ...

Over the past year, activist investors have increased their influence in the healthcare sector, targeting companies like Medtronic, Pfizer, and CVS Health to advocate for enhanced performance and ...

Wall Street was looking for $532 million, according to S&P Global Market Intelligence. Irish medical device maker Medtronic ...

Aktiia received FDA clearance in July for the first cuffless blood pressure monitor authorized to be sold over the counter.